about
Early pregnancy changes in bacterial vaginosis-associated bacteria and preterm delivery.Mycoplasma genitalium among young, urban pregnant women.Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease.Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges.Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease.Serum leptin measured in early pregnancy is higher in women with preeclampsia compared with normotensive pregnant women.Frequency of Chlamydia trachomatis-specific T cell interferon-γ and interleukin-17 responses in CD4-enriched peripheral blood mononuclear cells of sexually active adolescent females.Second trimester anti-angiogenic proteins and preeclampsiaEpidemiology, pathogenesis and treatment of pelvic inflammatory disease.Mid-pregnancy circulating immune biomarkers in women with preeclampsia and normotensive controls.Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials.Stimulating an immune response? Oral sex is associated with less endometritis.Abusive Experiences and Young Women's Sexual Health Outcomes: Is Condom Negotiation Self-Efficacy a Mediator?Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease.Prenatal Chlamydia trachomatis infection increases the risk of preeclampsia.The demographic, sexual health and behavioural correlates of Mycoplasma genitalium infection among women with clinically suspected pelvic inflammatory disease.Identification of novel microbes associated with pelvic inflammatory disease and infertilityClinical characteristics of bacterial vaginosis among women testing positive for fastidious bacteriaChlamydia trachomatis-infected patients display variable antibody profiles against the nine-member polymorphic membrane protein family.Diagnosis and treatment of pelvic inflammatory disease.Risk of sequelae after Chlamydia trachomatis genital infection in women.Chlamydia trachomatis infection may increase the risk of preeclampsia.Predictors of chronic pelvic pain in an urban population of women with symptoms and signs of pelvic inflammatory disease.Bacterial vaginosis and anaerobic bacteria are associated with endometritis.Endometritis does not predict reproductive morbidity after pelvic inflammatory disease.Does bacterial vaginosis cause pelvic inflammatory disease?Cross-sectional analysis of Toll-like receptor variants and bacterial vaginosis in African-American women with pelvic inflammatory disease.How does low back pain impact physical function in independent, well-functioning older adults? Evidence from the Health ABC Cohort and implications for the future.Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women.Preeclampsia and risk for epilepsy in offspring.Estrogen replacement, muscle composition, and physical function: The Health ABC Study.Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease.Lower quality of life among women with chronic pelvic pain after pelvic inflammatory disease.Mode of delivery and short-term infant health outcomes: a prospective cohort study in a peri-urban Indian populationPeak Expiratory Flow Is Not a Quality Indicator for SpirometryAssociation between allelic variants in cytokine genes and preeclampsiaDifferential distribution of allelic variants in cytokine genes among African Americans and White AmericansStability of Chlamydia trachomatis RNA after long-term biobank storageTrichomonas vaginalis, endometritis and sequelae among women with clinically suspected pelvic inflammatory diseaseNovel bacterial vaginosis-associated organisms mediate the relationship between vaginal douching and pelvic inflammatory disease
P50
Q33651214-300D34D8-EC29-409E-BE2F-75B7145C68D0Q33771940-57A39476-7F7D-42D3-A66F-93BC8D190274Q34591252-95C8F68B-DD92-4EA7-BE4C-8A7966A0D5B3Q35026625-095DD0A6-AE57-465E-9D66-9A47BF15F43BQ35056772-E7A0BAF0-65A2-48C5-8C61-C9712598AAD4Q35079373-3C0AD4C2-23F6-4F62-80B8-D294163D8D05Q35861640-DF1CA555-4D09-483A-9912-A64BACA55CF6Q36034224-BB3EA69F-758F-4ECB-AFA2-D5295A945E6EQ36441494-C4B0773C-EE0B-4A7E-B890-1591A0C60685Q36672096-DC1139E5-297F-42F6-8757-DD4B617DA5D5Q36753460-F6A79290-83DC-49F3-9CC2-7729BE8FEB8DQ36804355-BB14A11F-8835-42C1-A513-7BD6C6903946Q37008955-9C0797B5-9FEA-49EB-B763-2D66DAFF3133Q37056118-3BC51281-6604-4200-AD3D-FC4C27D17517Q37177830-FBB69DA8-F7EB-43AC-A526-E894918CDEBBQ37217710-BCD37A5D-C42D-45B4-B660-3A7F7866BFD4Q37235788-16032CCF-2BF3-473B-901B-835FECA5DBFEQ37255983-EC464B2E-F06E-4EEB-A9E5-9BAE0365B07FQ37274803-3736D2D7-0FFE-48F6-90F7-22F879D36319Q37346157-AB208B5E-1A7B-4AA8-BDA9-EAED436EB51BQ37752412-E564B8F8-F640-4FE7-9ADF-AE0F79FC9394Q37847371-EB364850-5BCF-4418-9DE5-126B96B73193Q37864999-9BFC83C8-C9E7-46BA-ABB6-4518EBD0B3EFQ37866320-15C34001-4A65-4FFF-99E4-17ABA28201CEQ37870296-B8CE9148-82C0-4397-BB15-89622E6A4B11Q38074562-29A10238-437F-49DE-8A94-E7E157669016Q39188698-A51D7A18-F539-46E2-BB4A-D22086548D07Q40534806-7756666D-BA74-4A92-9259-B68F9D30C16BQ44291205-A458F708-EF62-480D-ACB7-84666E25B671Q44400692-F552653F-94B9-4438-8E80-B09596EEC996Q46784202-13AA0FB2-9877-43A8-9228-8DC52B20AA8EQ48641123-FA915359-2DE1-42F1-99CB-E4BDE81159D0Q51944896-2F838B1F-585A-4A61-B522-B6CD4210B30FQ58605634-ADF64031-4865-4CF9-94FD-55B66689F8D3Q59538258-55337249-B29C-428D-B01A-5779524835E2Q80379753-B3B2279E-4DBE-4685-97CE-902950457C00Q81052909-AD68EF95-33E2-47AD-995B-9A6ABE25B3E2Q90811216-842B7FA2-FE8F-4B7C-812B-6EE66DC89753Q91259224-BE69A6FD-1912-4C1F-9EDB-68183A05A511Q91766378-49AE58F9-537A-4C05-91DA-AF610E5616F9
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Catherine L. Haggerty
@ast
Catherine L. Haggerty
@en
Catherine L. Haggerty
@es
Catherine L. Haggerty
@nl
Catherine L. Haggerty
@sl
type
label
Catherine L. Haggerty
@ast
Catherine L. Haggerty
@en
Catherine L. Haggerty
@es
Catherine L. Haggerty
@nl
Catherine L. Haggerty
@sl
prefLabel
Catherine L. Haggerty
@ast
Catherine L. Haggerty
@en
Catherine L. Haggerty
@es
Catherine L. Haggerty
@nl
Catherine L. Haggerty
@sl
P106
P1153
7004205915
P21
P31
P496
0000-0002-9849-7865